Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures

被引：0
|
作者：
Raquel Costa
Bernhard Steinhoff
Helena Gama
Fábio Ikedo
José-Francisco Rocha
Patrício Soares-da-Silva
机构：
[1] BIAL-Portela & Cª,Department of Research and Development
[2] S.A.,Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine
[3] Epilepsy Center Kork,MedInUP
[4] University of Porto,Center for Drug Discovery and Innovative Medicines
[5] University of Porto,undefined
来源：
Drugs & Aging | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1109 / 1117
页数：8
相关论文
共 50 条
  • [21] Analysis of Psychiatric Adverse Events and Suicidality in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 Years) with focal Seizures
    Salpekar, Jay
    Mintz, Mark
    Mintz, Pnina
    Grinnell, Todd
    Cantu, David
    Li, Yan
    Vieira, Mariana
    Pereira, Ana
    Blum, David
    NEUROLOGY, 2019, 92 (15)
  • [22] Analysis of Hematological and Serum Chemistry Abnormalities in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 Years) with Focal Seizures
    Kotagal, Prakash
    Loddenkemper, Tobias
    Grinnell, Todd
    Cantu, David
    Li, Yan
    Costa, Raquel
    Moreira, Joana
    Blum, David
    NEUROLOGY, 2019, 92 (15)
  • [23] Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
    Yang Jin
    Ranran Zhang
    Jing Jiang
    Xuewu Liu
    Acta Neurologica Belgica, 2023, 123 : 1081 - 1087
  • [24] Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
    Jin, Yang
    Zhang, Ranran
    Jiang, Jing
    Liu, Xuewu
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 1081 - 1087
  • [25] Eslicarbazepine acetate: A further pharmacological development as adjunctive therapy of focal epilepsy
    Stefan, Hermann
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (05): : 222 - +
  • [26] PRELIMINARY DATA ON THE EFFICACY AND TOLERABILITY OF ESLICARBAZEPINE AS ADJUNCTIVE THERAPY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY
    Boero, G.
    Francavilla, T.
    Interno, S.
    Clemente, G.
    Luisi, C.
    Pontrelli, G.
    Pappata, M.
    La Neve, A.
    EPILEPSIA, 2015, 56 : 52 - 52
  • [27] SAFETY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL-ONSET SEIZURES
    Trinka, E.
    Kowacs, P.
    Ben-Menachem, E.
    Elger, C.
    Moreira, J.
    Pinto, R.
    Ikedo, F.
    Pereira, A.
    Rocha, J. F.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A24 - A24
  • [28] COMPARATIVE ECONOMIC OUTCOMES IN PATIENTS WITH FOCAL SEIZURES INITIATING ADJUNCTIVE ESLICARBAZEPINE ACETATE VERSUS BRIVARACETAM AS THEIR FIRST ADJUNCTIVE BRANDED ASD
    Mehta, D.
    Davis, M.
    Epstein, A. J.
    Wensel, B.
    Grinnell, T.
    Thach, A.
    Williams, G. R.
    VALUE IN HEALTH, 2021, 24 : S159 - S159
  • [29] SAFETY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL-ONSET SEIZURES
    Trinka, E.
    Kowacs, P.
    Ben-Menachem, E.
    Elger, C.
    Moreira, J.
    Pinto, R.
    Ikedo, F.
    Pereira, A.
    Rocha, J-F
    Soares-da-Silva, P.
    EPILEPSIA, 2016, 57 : 186 - 187
  • [30] Analysis of Hepatic and Hypothyroidism-related Events in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 years) with focal Seizures
    Wheless, James
    Kothare, Sanjeev V.
    Grinnell, Todd
    Cantu, David
    Li, Yan
    Costa, Raquel
    Magalhaes, Luis M.
    Blum, David
    NEUROLOGY, 2019, 92 (15)
12345